Viral Clearance Using Traditional, Well-Understood Unit Operations: Session 1.2. Anion Exchange Chromatography; and Session 1.3. Protein A Chromatography

References

1. 1.↵
   1. Miesegaes G.,
   2. Bailey M.,
   3. Willkommen H.,
   4. Chen Q.,
   5. Roush D.,
   6. Blümel J.,
   7. Brorson K.

   Proceedings of the 2009 Viral Clearance Symposium. Dev. Biol. (Basel) 2010, 133, 3–101.

   OpenUrlPubMed
2. 2.↵
   1. Roush D.

   Viral clearance using traditional, well-understood unit operations (Session I): anion exchange chromatography (AEX). PDA J. Pharm. Sci. Technol. 2014, 68 (1), 23–29.

   OpenUrlFREE Full Text
3. 3.↵
   1. Miesegaes G.,
   2. Lute S.,
   3. Read E.,
   4. Brorson K.

   Viral clearance by flow-through mode ion exchange columns and membrane adsorbers. Biotechnol. Prog. 2013, 30 (1), 124–131.

   OpenUrl
4. 4.↵
   1. Hubbard B.,
   2. Roush D.

   Emerging unit operations (Session III): hydroxyapatite, mixed-mode, and adsorptive membrane chromatography; UV-C inactivation; chemical precipitation. PDA J. Pharm. Sci. and Technol. 2014, 68 (1), 51–65

   OpenUrl
5. 5.↵
   1. Staby A.,
   2. Johansen N.,
   3. Wahlstrom H.,
   4. Mollerup I.

   , Comparison of loading capacities of various proteins and peptides in culture medium and in pure state. J. Chrom., A 1998, 827 (2), 311–318.

   OpenUrlPubMed
6. 6.↵
   1. Strauss D. M.,
   2. Cano T.,
   3. Cai N.,
   4. Delucchi H.,
   5. Plancarte M.,
   6. Coleman D.,
   7. Blank G. S.,
   8. Chen Q.,
   9. Yang B.

   Strategies for developing design spaces for viral clearance by anion exchange chromatography during monoclonal antibody production. Biotechnol. Prog. 2010, 26 (3), 750–755.

   OpenUrlPubMed
7. 7.↵
   1. Norling L,
   2. Lute S.,
   3. Emery R.,
   4. Khuu W.,
   5. Voisard M.,
   6. Xu Y.,
   7. Chen Q.,
   8. Blank G.,
   9. Brorson K.

   Impact of multiple re-use of anion-exchange chromatography media on virus removal. J. Chrom., A 2005, 1069 79–89.

   OpenUrlPubMed
8. 8.↵
   1. Miesegaes G.,
   2. Lute S.,
   3. Brorson K.

   Analysis of viral clearance unit operations for monoclonal antibodies. Biotechnol. Bioeng. 2010, 106 (2), 238–246.

   OpenUrlPubMed
9. 9.↵
   1. Strauss D.,
   2. Lute S.,
   3. Tebaykina Z.,
   4. Frey D.,
   5. Ho C.,
   6. Blank G.,
   7. Brorson K.,
   8. Chen Q.,
   9. Yang B.

   Understanding the mechanism of virus removal by Q sepharose fast flow chromatography during purification of CHO-cell derived biotherapeutics. Biotechnol. Bioeng. 2009, 104 (2), 371–380.

   OpenUrlPubMed
10. 10.↵
    1. Brorson K.,
    2. Brown J.,
    3. Hamilton E.,
    4. Stein K.

    Identification of protein A media performance attributes that can be monitored as surrogates for retrovirus clearance during extended re-use. J. Chrom., A 2003, 989, 155–163.

    OpenUrlPubMed
11. 11.↵
    1. Lute S.,
    2. Norling L.,
    3. Hanson M.,
    4. Emery R.,
    5. Stinson D.,
    6. Padua K.,
    7. Blank G.,
    8. Chen Q.,
    9. Brorson K.

    Robustness of virus removal by protein A chromatography is independent of media lifetime. J. Chrom., A 2008, 1205 (1), 17–25.

    OpenUrlPubMed
12. 12.↵
    1. Shi L.,
    2. Chen Q.,
    3. Norling L. A.,
    4. Lau A. S.,
    5. Krejci S.,
    6. Xu Y.

    Real time quantitative PCR as a method to evaluate xenotropic murine leukemia virus removal during pharmaceutical protein purification. Biotechnol. Bioeng. 2004, 87 (7), 884–896.

    OpenUrlPubMed
13. 13.↵
    1. Hubbard B.

    Viral clearance by traditional operations with significant knowledge gaps (Session II): protein A chromatography. PDA J. Pharm. Sci. Technol. 2014, 68 (1), 13–16.

    OpenUrlFREE Full Text